Insulet news and events in 2026
Insulet provides tubeless, wearable insulin management systems for individuals with diabetes and other related conditions. The organization develops disposable, pod-based insulin pumps that deliver medication continuously without the use of tubing or the need for multiple daily manual injections.
Public (PODD)Medical Equipment Manufacturing1,001 to 5,000 employeesinsulet.comLinkedIn
- Dated updates
- 97
- Last event
- Sep 29, 2026
- Open rolesSnapshot Sep 29, 2026
- 67
- Latest SEC filing
- Sep 21, 2026
Overview
Insulet by topic
110-K filing
67open roles
2executive moves
68+signals
27 in the last 90 days
- Glassdoor15+
- LinkedIn15+
- Website changes15+
- YouTube12
- and 1 more sources
Latest events
Latest Insulet events
Showing 10 of 17 events. The Signal API returns all of them.
Get them with one API call- In developmentInsulet Reports Second-Quarter Revenue Growth as Full-Year U.S. Omnipod Outlook Is LoweredInsulet is developing Omnipod 6 and a fully closed-loop insulin delivery technology for people with type 2 diabetes, supported by new clinical data.
- LaunchInsulet Partners with Calm to Deliver Mental Health Tools for Diabetes CareInsulet has launched an enhanced automated insulin delivery algorithm for its Omnipod 5 system in the U.S. market.
- RevenueInsulet stock trades steady as diabetes device maker integrates latest Omnipod 5 performance and marInsulet reported total revenue in the hundreds of millions of dollars for a recent fiscal period, with mid to high double-digit percentage growth year-over-year.
- LaunchInsulet Corporation Partners with Calm to Provide Free Mindfulness Resources to Combat Anxiety and Burnout in People with DiabetesInsulet Corporation, in partnership with Calm, launched The Mind in Range Collection, a set of free mindfulness resources for the diabetes community.
- Office expansionInsulet Corporation Expands into Spain with Launch of Omnipod 5 and Omnipod DiscoverInsulet Corporation has expanded into Spain, its newest European market.
- Executive hireInsulet hires first chief R&D officer amid growing competition.Divakar Ramakrishnan, chief research and development officer
- Launch
- Launch
- In developmentDiabetes tech companies are racing toward 'fully closed loop' devices. But automation comes with trade-offs.Insulet Corporation is developing systems to take meal announcements out of diabetes management.
- Office expansionInsulet expands diabetes innovation with automated insulin delivery system launch in the Middle East.Insulet Corporation expands offices to Middle, New Jersey, United States, Northern America, Americas.
Showing 10 of 17 events. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Insulet with the Signal API
One POST /v1/companies/enrich call with insulet.com returns every signal type for Insulet, each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"insulet.com","limit":20}'Same industry
Companies related to Insulet
Insulet questions
What is the latest news on Insulet?
What is going on with Insulet?
What else does Autobound track for Insulet?
Is Insulet hiring right now?
Source. News, SEC filings (8-K, 10-K, 10-Q, Form D), hiring data and other signals (Reddit, podcasts, Glassdoor, reviews, social posts, patents, web traffic) from the Autobound Signal API.
Method. Stories are grouped when they report the same event within 14 days. Rows that do not name the company are removed. Each row links its source.
Data as of .